期刊
CURRENT PHARMACEUTICAL DESIGN
卷 28, 期 4, 页码 272-279出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612827666210329101335
关键词
Devic's disease; AQP4; autoimmunity; pathogenesis; therapy; NMOSD
This article reviews the recent advances in the diagnosis and treatment of patients with NMOSD, as well as the pathogenesis and mechanisms of AQP4-IgG-seropositive NMOSD.
Neuromyelitis optica spectrum disorder (NMOSD) is an acute or subacute demyelinating disease that affects mainly the optic nerve and spinal cord. A major proportion of NMOSD cases have a relationship with autoimmunity to aquaporin 4 (AQP4) found on the central nervous system. NMOSD can occur repeatedly, causing symptoms such as decreased vision and weakness of limbs. The main goal of the current therapy is to relieve acute symptoms and prevent recurrence of the disease. Without timely and appropriate treatment, the re-currence and disability rates are high. In the present work, we review recent advances in the diagnosis and treat-ment of patients with NMOSD, as well as the pathogenesis and mechanisms of AQP4-IgG-seropositive NMOSD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据